Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 96128

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
January 16, 2025
Product types
Drug
Classifications
Class III
Statuses
Completed
Recalling firm wording
Appco Pharma LLC

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.

D-0208-2025
Recall number
D-0208-2025
Initiated
January 16, 2025
Classification
Class III
Status
Completed
Recalling firm
Appco Pharma LLC
Quantity
1380 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet

Code information

Lot #: 2402101UR, Exp 02/28/2027

Distribution pattern

Nationwide USA.